Insider Trading Alert - Monsanto Company And 3 Others Traded By Insiders

Monday, July 8, 2013, 142 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1.15 to $10,873,958.42.

Highlighted Stocks Traded by Insiders:

Monsanto Company (MON) - FREE Research Report

Grant Hugh who is Chairman & CEO at MONSANTO CO-NEW bought 166,745 shares at $32.58 per share for a total value of $3,909,752.00 on July 3, 2013. Following this transaction, the Chairman & CEO owned 507,627 shares meaning that the stake was boosted by 39.62% with the 166,745 share acquisition.

Mizell Steven who is Exec. VP Human Resources at MONSANTO CO-NEW bought 78,976 shares at $74.39 per share for a total value of $6,886,467.65 on July 1, 2013. Following this transaction, the Exec. VP Human Resources owned 219,304 shares meaning that the stake was boosted by 36.85% with the 78,976 share acquisition.

The shares most recently traded at $100.53, up $1.34, or 1.35% since the insider transactions. Historical insider transactions for Monsanto Company go as follows:

  • 12-Week # shares sold: 160
  • 24-Week # shares sold: 30,160

The average volume for Monsanto Company has been 2.7 million shares per day over the past 30 days. Monsanto Company has a market cap of $52.6 billion and is part of the basic materials sector and chemicals industry. Shares are up 4.8% year to date as of the close of trading on Monday.

Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The stock currently has a dividend yield of 1.52%. The company has a P/E ratio of 21.2. Currently there are 11 analysts that rate Monsanto Company a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MON - FREE

TheStreet Quant Ratings rates Monsanto Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Monsanto Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

Hurricane Maria Has Quickly Become Another Category 5 Storm

Democrats Target Megamergers in Populist Political Play

Bayer, Monsanto Merger Under Scrutiny by EU Commission

Monsanto's Confusing Weed Killer Instructions Drive Farmers to Court